What is the event:

A webinar to provide an overview of the translation of Hyperpolarised 13C-MRI from preclinical to clinical cancer imaging.

Who should attend:

Suitable for any researchers who are interested and would like to find out more about the translation of Hyperpolarised 13C-MRI from preclinical to clinical cancer imaging.

Why should I attend:

To hear an overview of the latest research in Hyperpolarised 13C-MRI, as well as the latest updates on clinical studies and technical advances across NCITA partner institutions.

Full Agenda

14:00-14:05 Opening & Housekeeping - Dr Ramona Woitek & Prof. Evis Sala (Chairs)
14:05-14:25 Imaging tumour metabolism (13C and 2H) - Prof. Kevin Brindle, University of Cambridge
14:25-14:45 Clinical metabolic imaging - Prof. Ferdia Gallagher, University of Cambridge
14:45-15:00 Developing methods for the acquisition and post-processing of hyperpolarised 13C data - Dr James Grist, University of Oxford
15:00-15:15 Numerical optimization in magnetic resonance imaging of metabolism - Vencel Somai , University of Cambridge
15:15-15:25 Quantifying Hyperpolarised 13C-MR: What's the best metric? - Rafat Chowdhury, University College London
15:25-15:40 Questions and Discussion
15:40-15:50 BREAK
15:50-16:05 Imaging metabolic heterogeneity in breast cancer subtypes that are defined by their genomic profiles - Dr Susana Ros, University of Cambridge
16:05-16:20 Clinical hyperpolarised 13C-MRI in breast cancer - Dr Ramona Woitek, University of Cambridge
16:20-16:35 HP 13C MRI in renal cell carcinoma - Dr Stephan Ursprung, University of Cambridge
16:35-16:45 Imaging prostate cancer with hyperpolarised 13C-MRI: technical aspects - Dr Nikita Sushentsev, University of Cambridge
16:45-17:05 Hyperpolarised 13C-MRI of the prostate at UCL - Prof. Shonit Punwani, University College London
17:05-17:30 Questions, Discussion and Wrap up

NCITA Hyperpolarised 13C-MRI Webinar